Market Overview

Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel

Share:
Related ZGNX
What Investors Should Expect From Rockwell Medical's Next FDA Decision
Brean Capital Initiates Coverage On Zogenix

Shares of Zogenix (NASDAQ: ZGNX) rallied more than 10 percent on Tuesday following news the FDA rescheduled an advisory panel for hydrocodone drugs to January 24th-25th.

View pdf.

Posted-In: News FDA Movers

 

Related Articles (ZGNX)

Around the Web, We're Loving...

Get Benzinga's Newsletters